CMS advises Premium Equity Partners on acquisition of Human Med

Stuttgart – Private equity firm Premium Equity Partners has acquired Human Med AG, a technology leader in lipoedema treatment and regenerative medicine. Premium Equity Partners is acquiring the company from the current shareholders as part of a succession solution. The sole director, Bernd Lindner, will continue working for the company. The parties agreed not to disclose further details.

A CMS team headed by Dr Tobias Schneider advised Premium Equity Partners on all legal aspects of the transaction. The private equity firm has also previously relied on the expertise of the CMS team led by Dr Tobias Schneider.

CMS Germany

Dr Tobias Schneider, Lead Partner, Stuttgart
Christina Haußmann, Senior Associate, Stuttgart
Dr Maximilian Eitelbuß, Associate, Stuttgart, all Corporate/Private Equity
Dr Karsten Heider, Partner, Stuttgart
Maximilian Schneider, Principal Counsel, Stuttgart, both Stock Corporation Law
Dr Christian Haellmigk, Partner, Stuttgart
Malena Hansen, Senior Associate, Stuttgart, both Competition, Investment Control
Dr Roland Wiring, Partner, Hamburg
Dr Siham Hidar, Associate, Hamburg, both Regulatory 
Dr Michael Kraus, Partner, Stuttgart
Dr Arne Schmieke, Senior Associate, Cologne, both IT
Dr Stefan Voß, Partner, Stuttgart
Lukas Potstada, Senior Associate, Stuttgart, both Real Estate
Anne Waßmuth, Senior Associate, Stuttgart, Finance
Thomas Fröhlich, Senior Associate, Stuttgart, IP
Dr Jacob Hinze, Senior Associate, Hamburg
Can Kömek, Associate, Hamburg, both Labor, Employment & Pensions

Press Contact
presse@cms-hs.com